Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,334,698
+$1,213,331 QoQ
Shares Held
127,317
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#565
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. JNJ ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,334,698 | 127,317 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,121,367 | 127,317 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,382,382 | 132,314 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $29,991,685 | 161,750 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,921,433 | 195,885 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $32,485,568 | 195,885 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,271,040 | 195,485 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $31,283,252 | 193,035 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $28,447,851 | 194,635 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $31,081,962 | 196,485 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $31,518,062 | 201,085 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $30,921,826 | 198,535 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $33,104,000 | 200,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $30,217,250 | 194,950 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,172,942 | 193,450 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $32,516,808 | 199,050 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,540,519 | 200,217 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $35,759,165 | 201,767 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $36,594,781 | 213,917 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $34,531,445 | 213,817 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $36,137,695 | 219,362 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $36,932,896 | 224,721 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $34,269,495 | 217,750 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $32,493,060 | 218,250 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $30,748,749 | 218,650 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $28,835,487 | 219,900 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||